u/honest_syringe

Choose a format you will still be able to open in two years. Plain text or a spreadsheet you export beats an application that may not exist.

On the thin testing history in this board, and what to do about it.

Most of the compounds discussed here have a handful of independent results across the entire site, and several have none. That is a fact about how few members have paid for testing, not a judgement about the material.

What follows: buy small, test identity first for anything unusual, and post the result even when it is unremarkable. The vendor source pages are built from exactly these submissions, and the compounds with the thinnest coverage are the ones where one more entry changes the picture most. Research material is not approved for human use, so what this board can usefully build is an analytical record.

I would not read one person’s cycle-linked experience as a general pattern. The variation here is enormous.

Trial populations for the major programmes were not designed around the questions this board asks most often, which is why the evidence base here is genuinely thinner rather than merely harder to find.

catalogue depth is not the same as catalogue quality

Inter-lab variance on this assay runs roughly a point either way, driven mostly by gradient and integration.

This is why the template has a batch field. Without it the result is about a vial nobody can identify.

Careful. Naming a clinic without describing what actually happened turns this into a different kind of thread.

ask what the reference standard was

the pharmacy and the prescriber are two separate questions

Withdrawal studies in this class consistently show substantial regain after discontinuation. That is a pharmacological finding about a chronic condition, not a statement about anyone’s discipline.

This. The withdrawal data is not ambiguous and framing regain as a personal failure is both wrong and cruel.

I would not draw a trend line through that. Two points and a gap is not a series.

This. Asking what reference standard was used separates a real analytical claim from a plausible-looking one.

Small fix — fifteen residues, not seventeen.

Agreed — and the preclinical to clinical gap is where nearly all the overclaiming happens.

Reconstructed six weeks from memory once and later found receipts that contradicted my own log. Never again.

Why contemporaneous beats reconstructed, with the failure mode.

Memory smooths. Reconstructing a fortnight from recollection produces a series that is more regular, more consistent with your current beliefs, and quietly wrong in a direction that flatters the story you are already telling.

I found this out by reconstructing six weeks and later finding order receipts that contradicted my own entries. The log was not a little wrong; it was wrong in exactly the direction that made my narrative work. Write it down on the day, even the boring days, especially the boring days.

the log is cumulative, that is the whole value of it

Cosigning on planning it in advance. Deciding what maintenance looks like while still losing is much easier than deciding it in a panic.

Why the evidence base here is thin, which is not your imagination.

Disagreeing with this line: the absorption question has a product-specific answer and a pharmacist has it.

one result is a data point, agreement between two services is evidence

Adding the boring but useful bit: say whether you paid for it. It is the basis of the whole log.

Nothing in this thread is medical advice, and the choice between arrangements is one for you and a prescriber who knows your history.

no clinical trial has established what these threads assert

the human evidence is thin and the rodent evidence is not

Annotation is what makes a log survive contact with your future self. A single note beside an unusual week saves an hour of puzzled reconstruction later.

Attribution requires that one thing change at a time. A log with dose, training and intake all moving in the same fortnight cannot assign anything to any of them.

Built an elaborate spreadsheet, abandoned it by week nine, restarted with four columns and have kept it ever since.

Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.

do not assume the concentration matches the branded product

Asked QSC which lines they keep in regional stock versus make to order and got a clear split. It changed what I ordered.

Hormonal variation across the cycle affects appetite, fluid retention and subjective symptom intensity independently of anything else, which is why an unannotated log can look mysterious.

Bought small, tested identity first, and only then thought about anything else. That order felt right.

That is a purity figure, not an identity confirmation. Two different tests and only one answers the question asked.

the pharmacy and the prescriber are two separate questions

Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.

Was there potency testing on the finished preparation, or only on the starting material?

The template is vendor, compound, batch, service, claim, result, and who paid. Every one of those fields exists because a result missing it has been argued about here before.

Yes — date of analysis, because a result from two years ago describes a different manufacturing month.